Sign in
4

Changes in Ownership

PTC THERAPEUTICS, INC. Filed Acc 0001808968-26-000007

CHIEF EXECUTIVE OFFICER sold 2,514 shares at $76.45 ($192,195)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Klein Matthew B. · CHIEF EXECUTIVE OFFICER

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-01-08 Sale : show line 1 in the form 10b5-1 −2,514 $76.45 $192,195 394,453 D
Open-market sales · 2,514 sh · avg $76.45 · $192,195
Loading xslF345X05/form4-01122026_050107.xml…